Target intelligence / Profile preview

RNA, U6 small nuclear 27, pseudogene (RNU6-27P)

Target
RNU6-27P
Molecular classification
Pseudogene, Small nuclear RNA pseudogene
01

Overview

RNA, U6 small nuclear 27, pseudogene (RNU6-27P) is a **pseudogene** corresponding to a small nuclear RNA (snRNA) of the U6 type, annotated as the 27th member within this family. U6 snRNA normally plays an essential role in the nuclear splicing of pre-mRNA as a core component of the spliceosome; however, **pseudogenes like RNU6-27P do not encode functional RNA** and are considered non-functional genomic elements. Pseudogenes arise from gene duplication or retrotransposition events and often retain sequence similarity to their functional counterparts but lack the capacity to yield active transcripts or proteins. There is no evidence that RNU6-27P acts as a therapeutic target, participates directly in cellular processes, has any disease involvement, interacts with drugs, or serves as a biomarker[1][3]. If your intention is to reference the functional U6 small nuclear RNA itself, not a specific pseudogene, a separate and more functionally relevant entry would be "RNA, U6 small nuclear RNA" or "U6 snRNA," which is not synonymous with RNU6-27P[3][5]. **Key points:** - RNU6-27P is a **non-functional pseudogene**, not an active snRNA or therapeutic target[1][3]. - There are no validated disease associations, functional roles, drug interactions, or known therapeutic challenges specifically attributed to this pseudogene. - If there is an error, it is in treating the pseudogene as a biological or therapeutic target; the functional U6 snRNA is distinct[3][5].

Other names
RNU6-27RNU6-27P

Beyond the preview

Go deeper on RNA, U6 small nuclear 27, pseudogene (RNU6-27P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 27, pseudogene (RNU6-27P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call